AMRN

Amarin Corporation PLC News Headlines

$1.03
*  
unch
unch
Get AMRN Alerts
*Delayed - data as of Jan. 28, 2015  -  Find a broker to begin trading AMRN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    AMRN Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Amarin's Reduced Cash Burn Makes Dilution Less Likely
1/26/2015 12:32:00 PM - Seeking Alpha


Update: Amarin Estimates A $120 Million Year-End Cash Balance
1/14/2015 8:11:00 AM - Seeking Alpha


Amarin: Kowa Co-Promotion Agreement May Be Boosting Sales
1/5/2015 4:52:00 AM - Seeking Alpha


European ADRs Lifted by Pharmaceutical Stock Gains
12/24/2014 10:50:19 AM - MT Newswires


Good News: Vascepa Kept Its Place On National Formularies
12/17/2014 2:33:00 PM - Seeking Alpha


Amarin To Present At Oppenheimer Conference; Webcast At 3:20 PM ET
12/11/2014 2:20:00 PM - RTT News


Amarin Corporation: Upside Becomes Clearer While The Path To The Finish Line Remains Murky
12/7/2014 9:47:00 AM - Seeking Alpha


Amarin: The Silence Of The Lamb
12/2/2014 10:08:00 AM - Seeking Alpha


Why Amarin Corporation PLC Stock Flew 37% Higher in November
12/1/2014 2:14:54 PM - Motley Fool


Update: Amarin Earnings Show It Blew Its Chance At 2014 Profitability
11/24/2014 1:13:00 AM - Seeking Alpha


Amarin Corporation plc (AMRN) in Focus: Stock Soars 23.4% - Tale of the Tape
11/19/2014 9:18:00 AM - Zacks.com


Update: Amarin's Q3 2014 Earnings Report
11/10/2014 1:18:00 AM - Seeking Alpha


Amarin's Value With Or Without REDUCE-IT And A Final Word On Management
10/23/2014 12:30:00 AM - Seeking Alpha


Update: Amarin Announces Its Q3 2014 Cash Balance
10/20/2014 5:27:00 AM - Seeking Alpha


Amarin: REDUCE-IT And Debt Analysis Confirm That The Current Share Price Is An Opportunity
10/9/2014 11:30:00 AM - Seeking Alpha


CaPre Phase 2 trial hits all endpoints
9/30/2014 7:46:00 AM - Seeking Alpha


Following Biotech Stocks After Price Declines Of Greater Than 50%
9/25/2014 4:03:00 PM - Seeking Alpha


Where Should Amarin Go From Here?
9/24/2014 8:12:00 AM - Seeking Alpha


Roadmap Capital's Hugh Cleland And Stephen Ireland: Due Diligence Rules In Biotech Investment
9/18/2014 3:08:00 PM - Seeking Alpha


Update: Amarin REDUCE-IT Study - We Reaffirm Amarin Is A Speculative Play
9/16/2014 11:00:00 AM - Seeking Alpha


Amarin Plunges after the FDA Denies Vascepa SPA Appeal - Analyst Blog
9/15/2014 3:45:00 PM - Zacks.com


Dow Falls Over 100 Points; Ulta Salon Shares Jump After Earnings Report
9/12/2014 2:59:36 PM - Benzinga


Conversant Shares Rise On Acquisition News; Health Care REIT Drops
9/12/2014 1:02:16 PM - Benzinga


Update: Amarin Gets The Thumbs Down From The FDA....Again
9/12/2014 10:34:00 AM - Seeking Alpha


Markets Drop; Darden Adjusted Profit Beats Street View
9/12/2014 10:26:18 AM - Benzinga